Back to Search
Start Over
COVID-19 in Pediatric Granulomatosis with Polyangiitis
- Source :
- Pediatric Reports, Vol 13, Iss 4, Pp 31-34 (2021), Pediatric Reports
- Publication Year :
- 2021
- Publisher :
- MDPI AG, 2021.
-
Abstract
- The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulomatosis with polyangiitis and being treated with immunosuppressive drugs. We used lopinavir, ritonavir, hydroxy chloroquine, intravenous immunoglobulin and continuous veno-venous hemodialysis for treatment. Conclusion: In this patient, an underlying disease and delayed admission to the hospital were two factors complicating his condition.
- Subjects :
- medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
COVID19
medicine.medical_treatment
coronavirus
lcsh:Medicine
Case Report
wegener
medicine.disease_cause
Pediatrics
03 medical and health sciences
0302 clinical medicine
Chloroquine
030225 pediatrics
Internal medicine
medicine
Coronavirus
granulomatosis with polyangiitis
biology
business.industry
lcsh:R
lcsh:RJ1-570
Lopinavir
lcsh:Pediatrics
medicine.disease
biology.protein
Ritonavir
Hemodialysis
Antibody
business
Granulomatosis with polyangiitis
030217 neurology & neurosurgery
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 20367503
- Volume :
- 13
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Pediatric Reports
- Accession number :
- edsair.doi.dedup.....da7fe7cd57e75012080bfa6917b247ac